
Eisai
Asia, Tokyo, Japan, Tokyo
Description
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Investor Profile
Eisai has backed more than 8 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Japan, Singapore.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 1 rounds in the past year.
Stage Focus
- Series A (50%)
- Series C (25%)
- Series Unknown (13%)
- Pre Seed (13%)
Country Focus
- United States (38%)
- Japan (25%)
- Singapore (25%)
- Finland (13%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Medical
- Artificial Intelligence (Ai)
- Bioinformatics
- Clinical Trials
- Mobile Apps
- Wearables
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.